Table 1.
Author | Hagihara | Nakahara | Nakahara |
---|---|---|---|
Period | 2005–2008 | 2007–2010 | 2007–2010 |
Subset | NA | Shockable | Non-shockable |
Total number of cases | 417,188 | 14,943 | 81,136 |
ROSC | |||
ROSC with adrenaline (unadjusted) | 18.5% | 21.6% | 18.5% |
ROSC without adrenaline (unadjusted) | 5.7% | 28.1% | 5.7% |
Adjusted OR (95% CI) | 3.75 (3.59–3.91)a | NA | NA |
One-month survival | |||
One-month survival with adrenaline (unadjusted) | 5.4% | 16.5% | 3.9% |
One-month survival without adrenaline (unadjusted) | 4.7% | 28.8% | 4.2% |
Adjusted OR (95% CI) | 0.54 (0.43–0.68)a | 1.34 (1.12–1.60)b | 1.72 (1.45–2.04)b |
CPC 1–2 | |||
CPC 1–2 with adrenaline (unadjusted) | 1.4% | 6.9% | 0.6% |
CPC 1–2 without adrenaline (unadjusted) | 2.2% | 19.8% | 1.5% |
Adjusted OR (95% CI) | 0.21 (0.10–0.44)a | 1.01 (0.78–1.30)b | 1.57 (1.04–2.37)b |
aData adjusted for propensity and all covariates
bTime-dependent propensity score-matched data